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Differences in propionate-induced inhibition of cholesterol and 
triacylglycerol synthesis between human and rat hepatocytes in 
primary culture 
BY Y U G U A N G  LIN1, ROEL J. VONKl, MAARTEN J. H. SLOOFF2, 
F O L K E R T  KUIPERS'* A N D  M A R T I N  J. SMITl 
Hospital and State University of Groningen, The Netherlands 
Groningen Institute for  Drug Studies (GIDS), Departments of Pediatrics and Surgery, University 
(Received 4 July 1994 - Revised 6 December 1994 - Accepted 6 January 1995) 
Propionate is a short-chain fatty acid formed in the colon and supposedly involved in the cholesterol- 
lowering effect of soluble fibre. To explore the underlying mechanism(s) of this fibre action, we have used 
human hepatocytes in primary culture to study the effects of propionate on hepatic lipid synthesis. Initial 
experiments with mevalonate and mevinolin, a competitive inhibitor of hydroxymethylglutaryl (HMG)- 
CoA reductase (EC 1.1.1.88) were performed to evaluate basic regulatory mechanisms in these cells; 
results were compared with those obtained with rat hepatocytes. Incubation for 24 h with mevalonate 
caused a similar, concentration-dependeut inhibition of [14C]acetate incorporation into cholesterol in 
human and rat hepatocytes. Likewise, mevinolin (100 pmol/l) inhibited the formation of cholesterol 
from radiolahelled acetate by about 80% in cells from both species. Propionate inhibited cholesterol as 
well as triacylglycerol synthesis from [14C]acetate with a similar concentration-dependency in rat 
hepatocytes. Fifty percent inhibition was obtained at a propionate concentration of only 01 mmol/l. This 
propionate-induced inhibition was not affected by a 100-fold excess of unlahelled acetate. Human 
hepatocytes were much less susceptible in this respect: propionate concentrations of 10-20 mmol/l were 
required to obtain similar inhibitory effects in these cells, i.e. values greatly exceeding reported portal 
propionate concentrations in humans. The results suggest the existence of differences in the regulation 
of hepatic cholesterol (and triacylglycerol) synthesis between human and rat liver cells. These results do 
not support the hypothesis that the fibre-induced decrease in plasma cholesterol concentration in man is 
mediated by a direct effect of propionate on hepatic cholesterol synthesis. 
Liver: Cholesterol: Triacylglycerol: Short-chain fatty acids 
The liver is the major site of regulation of body cholesterol homeostasis (Dietschy, 1986). 
Regulatory steps in hepatic cholesterol metabolism have been studied extensively using 
cultured rat hepatocytes and human hepatoma cells. Potential drawbacks of using animal 
or tumour cells concern the well-established species-specific and tumour-specific charac- 
teristics respectively, of hepatic cholesterol metabolism. Cultured human hepatocytes 
therefore provide a very useful tool to obtain information on human-specific characteristics 
of hepatic cholesterol metabolism. A few studies on cholesterol metabolism have been 
performed so far using human hepatocytes. From these studies it has become clear that in 
vitro these cells express low-density-lipoprotein (LDL)-receptor activity (Edge et al. 1986 ; 
Hoeg et al. 1986; Kamps et al. 1991) and high-affinity binding sites for @-migrating very- 
low-density lipoprotein V-VLDL) (De Water et al. 1992) and apolipoprotein E-free high- 
density lipoprotein (HDL) (Schouten et al. 1990). In addition, they have been shown to 
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synthesize and secrete bile acids (Princen et al. 1986), albumin (Forte et al. 1989), and 
lipoproteins (Forte et al. 1989). Furthermore, apolipoprotein B secretion by human 
hepatocytes is inhibited by insulin (Salhanick et al. 1991), a phenomenon also observed 
with rat hepatocytes. Regulation of LDL-receptor activity in human hepatocytes in 
response to incubation with LDL and heavy HDL has been demonstrated by Havekes et 
al. (1986). 
The high incidence of coronary heart disease in Western countries is, at least in part, 
related to nutritional factors that interact with cholesterol metabolism. Dietary fibre is one 
of the dietary components known to affect cholesterol metabolism in humans and 
experimental animals (Kritchevsky, 1986). In particular, water-soluble fibre has been 
suggested for use as a serum-cholesterol-lowering, anti-atherogenic agent (Kirby et al. 
1981 ; Anderson et al. 1984). One of the proposed mechanisms for the hypocholesterolaemic 
effect of soluble fibre is through the action of propionate, a short-chain fatty acid that arises 
from fibre fermentation in the colon (Chen & Anderson, 1984). Propionate has been 
reported to inhibit lipid synthesis in vitro in rat hepatocytes (Nishina & Freedland, 1990; 
Wright et al. 1990). For the present studies we have used human hepatocytes in primary 
culture to study the human-specific effects of propionate on lipid synthesis and have 
compared the results with those obtained with rat hepatocytes. 
M A T E R I A L S  AND METHODS 
Materials 
[2J4C]Acetic acid (2097 kBq/mmol) and ~-[4,5-~H]leucine (2257 GBq/mmol) were ob- 
tained from the Radiochemical Centre Ltd., Amersham, Bucks. Mevinolin (MK-803) was a 
kind gift from the Merck, Sharp and Dohme Research Laboratory, Rahway, NJ, USA. 
Mevalonic acid lactone was purchased from Sigma Chemical Co., St. Louis, MO, USA. 
Insulin (Actrapid, 100 IU/ml) was from Novo Nordisk Industry A/S (Copenhagen, 
Denmark). Thin-layer chromatography (TLC) precoated silica gel 60 plates and all salts 
and solvents were obtained from E. Merck (Darmstadt, Germany). 
Rat hepatocytes 
For isolation of rat hepatocytes, male Wistar rats weighing 180-220 g were used. Rats were 
maintained in a light- and temperature-controlled room. Lights were on from 06.00 to 
18.00 hours. Water and pellet food (RMH-B, Hope Farms, The Netherlands) were 
available ad lib. Hepatocytes were isolated according to the method of Berry & Friend 
(1969) and cultured exactly as described below for human hepatocytes. 
Human hepatocytes 
Human liver tissue was obtained from livers harvested from multiorgan donors (two 
female, five male, aged 5-42 years). Consent from legal authorities and family was obtained 
for the explantation of organs for transplantation purposes. The donor livers were split to 
perform reduced-size liver transplants in children. The liver tissue remaining after the 
splitting procedure was used for the isolation of hepatocytes. Some livers discarded for 
transplantation after harvesting were used as well. Livers were perfused with UW 
(University of Wisconsin) solution (Kalayoglu et al. 1988) and stored in this buffer at 4" 
until the start of the isolation procedure. Hepatocytes were isolated from 13-130 g pieces 
of liver tissue as described by Sandker et al. (1994), after 6 to 41 h preservation in UW 
solution. When the viability of the cells, as judged by Trypan Blue exclusion, was lower 
than 70 % the non-viable cells were separated from viable ones by suspending the cells in 
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36 % Percoll, followed by centrifugation for 10 min at 100 g. The Percoll solution with non- 
viable cells on top was discarded and the pellet consisting of viable hepatocytes was washed 
and resuspended in Krebs-Henseleit buffer and the number of cells was counted. 
Cells were cultured as described previously (Princen et al. 1986). In short, the cells were 
washed twice in the culture medium described below and seeded on 6-well cluster plates 
(35 mm diameter; Costar, Cambridge, MA, USA) at a density of 1.5 x lo6 cells/well and 
were maintained in Williams E medium supplemented with 100 g heat-inactivated fetal 
bovine serum/l, 2 mM-L-glutamine, 4 mU insulin/ml, 50 nM dexamethasone, 100 IU 
penicillin/ml, and 100 yg streptomycin/ml at 37" in a C0,-air (5:95 v/v) atmosphere. 
After attachment of the cells (4-16 h) the medium was renewed with 2 ml culture medium 
after which medium was renewed every 24 h. 
Analyses 
Cholesterol and cholesterol ester were determined, after extraction (Bligh & Dyer, 1959), 
according to the method of Gamble et al. (1978). Protein was determined according to the 
method of Lowry et al. (1959) with bovine serum albumin as a standard. Lactate 
dehydrogenase (EC 1 . 1 . 1 .27) in medium and cells was determined as described previously 
(Smit et al. 1988). Protein synthesis from [3H]leucine was measured after 1 h incubation of 
cells in serum-free medium containing 185 kBq [3H]leucine. The amount of newly 
synthesized protein in the cells was measured by precipitation of the protein in 
trichloroacetic acid (100 g/l). After centrifugation for 10 min at 12000g (4") the pellet was 
washed three times by repeated sonication and centrifugation. The precipitated protein was 
solubilized overnight at 4" in 1 ml of a 1.1 5 M-NaOH solution containing 11.5 g/1 sodium 
dodecyl sulphate and the amounts of radioactivity and protein were determined. 
Experimental procedures 
After 2-4 d in culture (depending on the type of experiment, see below), cells were washed 
twice with serum-free medium and the effects of various treatments on cholesterol and in 
some cases triacylglycerol synthesis were determined by measuring incorporation of 
[14C]acetate into cholesterol and triacylglycerols by incubation for 1 h in 2 ml serum-free 
medium containing 185 kBq [14C]acetate (0.1 mmol/l). After 1 h cells were put on ice, and 
medium and cells were harvested. Cellular lipids were extracted (Sligh & Dyer, 1959) and 
lipids were saponified in tubes containing 20 ,ug and 20 000 disintegrations/min (dpm) 
[3H]cholesterol as an internal standard, 45 pl glycerol and 3.5 ml ethanolic KOH (57 g/l) 
for 1 h at 90". The solution was dried under N, and after a second extraction the lipids were 
separated by TLC with benzene-ethylacetate (2: 3, v/v) as a solvent. The cholesterol spot 
was located by I, vapour, scraped off and the radioactivity was measured in a liquid 
scintillation counter (LKB Instruments, Uppsala, Sweden) equipped with an external 
standard to correct for quenching. The amount of labelled triacylglycerol was determined 
after extraction of cellular lipids and TLC using hexane-diethyl ether-acetic acid (80 : 20: 1, 
by vol.) as a solvent. 
For experiments on the effect of mevalonate on the incorporation of [14C]acetate into 
cellular cholesterol, mevalonate was added to concentrations of 1-10 mmol/l. Mevalonate 
was obtained from mevalonolactone after incubation in 0 1  M-NaOH (56", 15 min). For 
these experiments cells that had been cultured for 4 d in serumcontaining medium were 
used. The medium was changed to serum-free medium containing mevalonate and after 
23 h [14C]acetate was added, followed by incubation for another hour, and the amount of 
labelled cholesterol was determined as described above. The short-term effect of mevalonate 
was determined during 1 h incubation in serum-free medium in the presence of 5 mM- 
mevalonate. In experiments on the effects of mevinolin, 5yl  of a mevinolin solution in 
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ethanol was added to 2 ml culture medium to obtain a final concentration of 100 pmolll 
and cells were incubated for 1 h in the presence of [14C]acetate. 
Experiments with propionate were performed with cells that had been cultured for 2 d 
in serum-containing medium. Cells were washed twice with serum-free medium and the 
incorporation of [14C]acetate into cholesterol and triacylglycerols was measured as 
described above during 1 h incubations in the absence and presence of propionate at 
concentrations of 0.1-50 mmol/l. 
Statistics 
Results are presented as dpm/mg protein per h for individual experiments (mean of 
triplicate measurements) and as percentage of control values when data from separate 
isolations are combined. Student’s t test was used to evaluate the statistical significance of 
differences with the control situation, with a P value < 0-05 considered as significant. 
R E S U L T S  
Cholesterol synthesis from [14C]acetate in human hepatocytes 
Cholesterol synthesis was estimated in the present study from the incorporation of 
radiolabelled acetate into the sterol. Incorporation of [14C]acetate into cholesterol in the 
various preparations of human hepatocytes showed large variation and tended to decrease 
with increasing time in culture. Thus, in 2-d-cultured cells (three preparations, used for 
propionate experiments) the basal incorporation rates (mean of triplicate measurements) 
were 90740 (SE 14930), 87230 (SE 6680), and 53600 (SE 9110) dpm/mg protein per h 
respectively. Values for 4-d-cultured cells (four preparations, used for meValonate/ 
mevinolin experiments) were 14590 (SE 1690), 67670 (SE 7520), 2400 (SE 360), and 1870 
(SE 60) dpm/mg protein per h respectively. No clear relationship between incorporation rate 
on the one hand and donor age, sex or preservation time on the other hand was observed, 
nor were clear differences observed between cells isolated from discarded livers and those 
from transplanted ones. On average, synthesis by human hepatocytes was markedly higher 
than by rat hepatocytes cultured in parallel, i.e. mean 45440 (SE 14690; rz 7) v. mean 4210 
(SE 1130; n 9) dpm/mg protein per h respectively. 
Efects of mevalonate and mevinolin 
Incubation of human and rat hepatocytes with different concentrations of mevalonate for 
24 h resulted in similar concentration-dependent down-regulation of cholesterol synthesis 
from [14C]acetate (Fig 1). Incubation of rat hepatocytes for only 1 h in the presence of 
5 mM-mevalonate resulted in down-regulation by 85 Yo compared with the control value 
(Fig. 1 (b)). Human hepatocytes showed a smaller decrease after a 1 h incubation, i.e. by 38 YO 
(Fig. 1 (a)). The masses of cholesterol and cholesterol ester were slightly higher in rat (16.92 
(SE 2.27) and 434 (SE 9-57) ,ug/mg protein respectively) than in human cells (13.75 (SE 1.85) 
and 2.23 ( ~ ~ 0 . 3 6 )  pg/mg respectively). The amount of cholesterol ester was only 
marginally, i.e. by 20-30 YO, increased by mevalonate in rat hepatocytes, but more strongly 
in human cells, i.e. by 6&160Y0, depending on the mevalonate concentration. To see 
whether the slow inhibition of cholesterol synthesis was specific for the human cells, we 
carried out a similar experiment with the human hepatoma cell line HepG2. With these cells 
we observed a similar concentration-dependent down-regulation after 24 h incubation with 
mevalonate as in the primary cultures. Like the human hepatocytes, the HepG2 cells 
showed only a relatively small inhibition of cholesterol synthesis from radiolabelled acetate, 
i.e. by 30%, when incubated for 1 h with 5 mM-mevalonate (Fig. l(c)). 
Mevinolin (100 pmol/l) caused a similar inhibition of the incorporation of radiolabelled 
acetate into cholesterol in human and rat hepatocytes, i.e. to 16 (SE 11) % and 20 (SE 12) YO 
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Fig. 1. Effect of mevalonate on the incorporation of [14C]acetate into cholesterol in (a) human hepatocytes, (b)  rat 
hepatocytes and (c) HepG2 cells. Cells were incubated for 24 h in serum-free medium containing the indicated 
amount of mevalonate. After 23 h [14C]acetate was added to the medium followed by incubation for another 
1 h. At 24 h cells and medium were harvested and analysed as described on p. 199. Hatched bars indicate 
incubations for 1 h in serum-free medium with 5 mwmevalonate. Values are means for triplicate determinations 
of three different cell preparations, with their standard errors indicated by vertical bars. Total (100%) values for 
cholesterol synthesis were: human hepatocytes 23779 (SE 37838), rat hepatocytes 1947 (SE 496) and HepG2 cells 
15062 (SE 10060) dpm/mg protein. *Mean values were significantly different from the control, P < 005. 
(three preparations of each species) of the control values respectively. No significant effects 
on the cellular amounts of free and esterified cholesterol were observed. 
ESfect of propionate on [14C]acetate incorporation into cholesterol and triacylglycerols 
When human hepatocytes were incubated in the presence of different concentrations of 
propionate, a concentration-dependent inhibition of cholesterol and triacylglycerol 
synthesis from [14C]acetate was observed, with 50 % inhibition occurring at a concentration 
of about 20 mmol/l (Fig. 2). The same experiment with rat hepatocytes showed inhibition 
at much lower concentrations of propionate, i.e. 50% inhibition at about 0.1 mmol/l. In 
both species inhibition of cholesterol and triacylglycerol fatty acid synthesis took place in 
a parallel fashion (compare Figs. 2(a) and 2(b). As a result, the amount of [14C]acetate 
incorporated into cholesterol relative to triacylglycerol was fairly constant over the range 
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Fig. 2. Effect of propionate on (a) cholesterol and (b) triacylglycerol synthesis from ['*]acetate by human (0) and 
rat (0) hepatocytes in culture. Synthesis rates were determined during a 1 h incubation period in the absence and 
presence of the indicated concentrations of propionate. Values are means of triplicate determinations from three 
different cell preparations, with their standard errors indicated by vertical bars. The 100% values for cholesterol 
synthesis were: human hepatocytes 103 600 (SE 53400), rat hepatocytes 9290 (SE 1987) dpm/mg protein, and those 
for triacylglycerol synthesis were: human hepatocytes 55300 (SE 29900), rat hepatocytes 17960 (SE 4960) dpm/mg 
protein. * Mean values for human hepatocytes were significantly different from controls, P < 0.05. ** Mean values 
for rat hepatocytes were significantly different from controls from a propionate concentration of 0.1 mmol/l 
upward (asterisks not included in Fig. for reasons of clarity). For details of procedures, see pp. 198-200. 
of propionate concentrations used. In rat hepatocytes the ratio between 14C incorporated 
into triacylglycerol and cholesterol was about 2.5 : 1. With two preparations of human 
hepatocytes values of < 0.5 : 1 were observed. In another preparation this ratio was about 
2 :  1. 
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Fig. 3. Effect of different concentrations of acetate on the inhibition by propionate of [Wlacetate incorporation 
into cholesterol in rat hepatocytes. Rat hepatocytes were incubated in serum-free medium for 1 h in the presence 
of 185 kBq ['*C]acetate at  concentrations of 0.1, 5.1 and 10.1 mmol/l in the absence (0) or presence (m) of 
0.5 mwpropionate. Results are shown as a percentage of the control incubations with 0.1 mwacetate and 
represent means of determinations from three cell preparations with their standard errors indicated by vertical 
bars. The insert shows the same results, but in this case the value of the incubation without propionate (0) at each 
concentration of 0.1, 5.1 and 10.1 mM-acetate is taken as 100%. For details of procedures, see pp. 198-200. 
Table 1. Efect of propionate on protein synthesis by cultured human and rat hepatocytes, 
and on leakage of lactate dehydrogenase (LDH; EC 1 .  I .  1.27) into the medium' 
(Mean values with their standard errors for triplicate determinations from three different cell preparations) 
Protein synthesis LDH leakage 
(dpm/mg protein per h) 
Propionate 
(mmol/l) Mean SE Mean SE 
(% cellular activity) 
Rat hepatocytes 
0 9760 3870 7.4 3.3 
5 8660 3400 7.8 5.3 
10 ND 8.0 5.1 
50 ND 8.1 5.8 
0 15 970 1540 7.6 0.4 
5 17 170 1860 8.5 2.0 
10 ND 5.2 1.3 
50 ND 6.3 1.3 
Human hepatocytes 
ND, not determined. 
*For details of procedures, see pp. 198-200. 
To check the possibility that the observed effect on lipid synthesis from [14C]acetate was 
the result of dilution of the substrate pool used for cholesterol synthesis, we carried out an 
experiment using rat hepatocytes in the presence of a constant concentration of 
propionate (05 mmol/l) and different concentrations of acetate, i.e. 0.1 m~-[l~C]acetate in 
the presence of 0, 5 or 10 mmol/l unlabelled acetate. The amount of acetate present did not 
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affect the propionate-induced inhibition of cholesterol synthesis from radiolabelled acetate, 
as shown in Fig. 3. A similar result was obtained for triacylglycerol synthesis (results not 
shown). 
Protein synthesis from [3H]leucine and leakage of lactate dehydrogenase from the cells 
was measured in the presence or absence of different concentrations of propionate. As 
shown in Table 1, there was no effect of propionate on these variables. 
DISCUSSION 
The results of the present study demonstrate that human hepatocytes under the culture 
conditions employed, in general, express similar ‘basic features’ in their regulation of 
cholesterol synthesis to those of rat hepatocytes. Thus, synthesis in cells of human and rat 
origin was strongly inhibited by physiological (mevalonate, propionate) and pharma- 
ceutical (mevinolin) agents and stimulated in the presence of human HDL (150 pg 
cholesterol/well; results not shown). However, marked quantitative differences between 
the cells from both species were observed that in the case of propionate-induced effects may 
be indicative of physiologically relevant species differences in the regulation of hepatic 
lipid synthesis. 
In these studies we applied radiolabelled acetate to estimate cholesterol (and 
triacylglycerol) synthesis ; because of the well-established compartmentalization of cellular 
acetate this method does not allow the calculation of absolute synthesis rates (Turley & 
Dietschy, 1982), and values were expressed as dpm/mg protein or as relative changes 
compared with control conditions. Although [14C]acetate is not suitable for determination 
of absolute synthesis rates, as discussed in detail by Turley & Dietschy (1982), it has been 
demonstrated that the relative changes in cholesterol biosynthesis measured by this method 
in cultured cells under different experimental conditions are in close agreement with values 
obtained with tritiated water (Davis eb al. 1982). 
On average, [14C]acetate incorporation into cholesterol was higher in human hepatocytes 
than in rat hepatocytes. Under normal feeding conditions the rat appears to have a 
relatively high rate of hepatic and total body cholesterol synthesis when compared with 
other animal species (Turley & Dietschy, 1982). Likewise, the absolute synthesis of 
cholesterol measured by 3H,0 in liver slices was found to be five times higher in rat than 
in human liver (Turley & Dietschy, 1982). On the other hand, using the newly developed 
technique of mass isotopomer distribution analysis (MIDA) with infusion of [Tlacetate, 
Hellerstein and co-workers (Neese et al. 1993) very recently calculated values for total body 
cholesterol synthesis in vivo of 9 to 10 mg/kg per d and 8.9 mg/kg per d in healthy female 
volunteers and male rats respectively. The relative contribution of the liver to total 
synthesis amounts to 60 % in rats (Turley et al. 1981) but is unknown in humans. Therefore, 
the relevance of the observed higher acetate incorporation in human cells in vitro when 
compared with rat cells is difficult to evaluate. It may reflect a difference between the cells 
of the two species in response to the culture conditions, a possibility supported by 
differential effects of the presence of fetal bovine serum and human lipoproteins in the 
meda on cholesterol synthesis and cellular cholesterol ester content in human and rat cells 
(Y. Lin, R. Havinga, M. J. Smit and F. Kuipers, unpublished results). It may also be a 
metabolic effect of the preservation of human liver tissue in UW solution; this possibility 
is currently under investigation in our laboratory. On the other hand, it may be a reflection 
of differences in the size of cytosolic acetate pools between human and rat cells, a factor 
that may also contribute to the marked variability in acetate incorporation between the 
different human hepatocyte preparations. Nevertheless, mevinolin, a competitive inhibitor 
of hydroxymethylglutaryl (HMG)-CoA reductase (EC 1 . 1 . 1 .88), and mevalonate inhibited 
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the incorporation of [14C]acetate into cholesterol to the same extent in cells from both 
species, independent of the basal incorporation rates. Mevalonate, formed from 
hydroxymethylglutaryl (HMG)-CoA in a reaction catalysed by HMG-CoA reductase (EC 
1 . I  . 1 .88), has been shown to influence cholesterol metabolism via both sterol (possibly 
oxysterols) and non-sterol products (Goldstein & Brown, 1980; Nakanishi et al. 1988). 
Drevon et al. (1980) showed that, on incubation of rat hepatocytes with mevalonate 
(1 mmol/l), HMG-CoA reductase activity decreased to a level of about 20 % of the control 
value within 1 h. We observed a similar, dose-dependent decrease in cholesterol synthesis 
from [14C]acetate in rat and human hepatocytes, as well as in HepG2 cells, after 24 h 
incubation with different concentrations of mevalonate. After only 1 h incubation with 5 
mwmevalonate a strong inhibition was observed in rat hepatocytes, in agreement with the 
results of Drevon et al. (1980). Both in human hepatocytes and in HepG2 cells the 
inhibition was less pronounced after 1 h, indicating that human cells do not react as rapidly 
as rat cells to changes in cholesterol availability. Accordingly, an increased amount of 
cholesterol ester was found in human hepatocytes and in HepG2 cells, but not in rat cells, 
after incubation with mevalonate. 
The interference of propionate with hepatocytic cholesterol synthesis was studied to see 
whether propionate may act as a mediator of the cholesterol-lowering effect of soluble fibre 
in humans. Propionate, as well as the other short-chain fatty acids acetate and butyrate, is 
formed by fermentation of soluble and insoluble fibres by colonic microflora. After 
absorption it is effectively cleared by the liver (Dankert et al. 1981). 
Propionate has been shown to lower serum cholesterol concentrations when fed to rats 
(Illman et al. 1988) and to inhibit the synthesis of cholesterol (and of fatty acids) from 
[14C]acetate in freshly isolated rat hepatocytes (Nishina & Freedland, 1990; Wright et al. 
1990) in the concentration range observed in the portal blood of rats fed on high-fibre diets, 
i.e. up to 0.8 mmol/l (Illman et al. 1988). Very recently, Todesco et al. (1991) reported that 
supplementing the diet of healthy volunteers with sodium propionate (9-9 g/d) for 1 week 
tended to reduce LDL-cholesterol concentrations, with an average reduction of 
0.37 mmol/l. However, HDL-cholesterol was also reduced and the triacylglycerol 
concentration was increased in five out of the six subjects studied. 
Using rat hepatocytes in primary culture, we found a parallel , dose-dependent inhibition 
of cholesterol and triacylglycerol synthesis from [14C]acetate, with 50 YO inhibition 
occurring at a propionate concentration as low as 0.1 mmol/l. Propionate did not exert 
overt toxic effects on liver cells, as concentrations up to 5 mmol/l did not affect protein 
synthesis and lactate dehydrogenase leakage from the cells. The mechanism of propionate- 
induced inhibition of lipid synthesis in rat hepatocytes is unclear. Using a 10- and 100-fold 
excess of radiolabelled acetate, we have excluded the theoretical possibility that propionate 
competes with acetate for lipid synthesis, in other words that the decreased incorporation 
of radiolabel into cholesterol is due to dilution of the precursor pool rather than to 
inhibition of synthesis. It may be that propionate acts on cholesterol and triacylglycerol- 
fatty acid synthesis by affecting the activity of a common key enzyme, e.g. acetyl-CoA 
synthetase (EC 6.2.1.3), as suggested by the parallel fashion of inhibition of both lipids. 
Recently, Gordon & Crabtree (1992) reported a strong inhibition of cytoplasmic acetyl 
CoA synthesis by 2 mM-propionate in freshly isolated rat hepatocytes. Potential 
mechanisms also include alteration of the cytosolic citrate concentration and redistribution 
of CoA (Brass & Ruff, 1992). Conflicting results on this issue have recently been reported. 
Wright et al. (1990) and Nishina & Freedland (1990) found that the synthesis of both 
cholesterol and fatty acids from [ l-14C]acetate was inhibited by propionate in freshly 
isolated rat hepatocytes. However, Wright et al. (1990) reported that synthesis of 
cholesterol, but not that of fatty acids, was inhibited by propionate when 3H,0 was used 
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to quantify lipid synthesis, whereas exactly the opposite was found by Nishina & Freedland 
(1990). Clearly, more research is needed to clarify this issue. 
Propionate concentrations have been determined in human portal blood obtained at 
autopsy of sudden death victims (within 4 h of death; Cummings et al. 1987) and during gall- 
bladder surgery (Dankert et al. 1981). Values ranging from 0-017 - 0.194 mmol/l and 
0.004-0.108 mmol/l respectively were found. Obviously, it is not known how these values 
relate to ‘physiological values’, for instance the levels reached after a fibre-rich meal. 
Nevertheless, the measured values are orders of magnitude lower than the propionate 
concentrations required to inhibit cholesterol (and fatty acid) synthesis in cultured human 
hepatocytes, i.e. 10-20 mmol/l. The reason(s) for the large difference in susceptibility to 
propionate-induced inhibition of lipid synthesis between human and rat hepatocytes is not 
known. The extremely high concentration needed in human cells suggests an aspecific mode 
of action, like altering the available amount of CoA (Brass & Ruff, 1992), whereas in rat 
cells a more specific, potentially ‘regulatory ’ mechanism may operate. These results, 
therefore, do not support the hypothesis that the cholesterol-lowering effect of soluble fibre 
in man is mediated by a direct action of propionate on hepatic cholesterol synthesis. In 
addition, the very distinct species-differences in susceptibility of lipid synthesis to the 
inhibitory effects of propionate between human and rat cells delineate the suitability of the 
human hepatocyte system as a model of choice to study the regulation of human hepatic 
cholesterol metabolism by dietary factors. 
This study was supported by grants from the Netherlands Ministry of Health and the 
Fokkens-Kerkhoff Foundation. YL is supported by the Royal Netherlands Academy of 
Arts and Sciences. FK is an established investigator of the Netherlands Heart Foundation. 
These studies were performed in collaboration with the Groningen Human Liver Group. 
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